Abdulmaged M. Traish

Affiliations: 
Boston University, Boston, MA, United States 
Area:
Molecular Biology, Biochemistry, Oncology
Google:
"Abdulmaged Mohamed Traish"
Bio:

https://books.google.com/books?id=gkkoAQAAIAAJ

Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Herbert H. Wotiz grad student 1978 Boston University
 (Subcellular interactions of estrogens in rat uterus.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Traish AM. (2016) Testosterone Therapy in Men with Testosterone Deficiency: Are the Benefits and Cardiovascular Risks Real or Imagined? American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. ajpregu.00174.2016
Traish AM, Zitzmann M. (2015) The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease. Reviews in Endocrine & Metabolic Disorders. 16: 249-68
Morgentaler A, Zitzmann M, Traish AM, et al. (2015) International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic. The Aging Male : the Official Journal of the International Society For the Study of the Aging Male. 1-2
Traish AM, Haider KS, Doros G, et al. (2015) Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. Hormone Molecular Biology and Clinical Investigation. 23: 85-96
Morgentaler A, Miner MM, Caliber M, et al. (2015) Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clinic Proceedings. 90: 224-51
Traish AM, Morgentaler A, Khera M. (2015) RE: Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology. 156: L1-2
Traish AM, Melcangi RC, Bortolato M, et al. (2015) Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know? Reviews in Endocrine and Metabolic Disorders
Traish AM, Guay AT, Zitzmann M. (2014) 5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis. Hormone Molecular Biology and Clinical Investigation. 20: 73-80
Traish AM. (2014) Testosterone and weight loss: the evidence. Current Opinion in Endocrinology, Diabetes, and Obesity. 21: 313-22
Traish AM, Mulgaonkar A, Giordano N. (2014) The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression. Korean Journal of Urology. 55: 367-79
See more...